Clinical Trials on Hematologic Malignancies in United Kingdom
Total 8332 results
-
CelgeneActive, not recruitingNeoplasms | Hematologic Malignancies | Hematologic NeoplasmUnited Kingdom, United States
-
AdaptimmuneRecruitingSolid and Hematological MalignanciesUnited States, Spain, Canada, United Kingdom
-
Kite, A Gilead CompanyEnrolling by invitationSolid and Hematological MalignanciesUnited States, Netherlands, Japan, Australia, France, Israel, Germany, Canada, United Kingdom
-
Baylor College of MedicineCenter for Cell and Gene Therapy, Baylor College of MedicineCompletedMyeloid Hematological MalignanciesUnited States
-
Medical College of WisconsinCompletedMalignancies, HematologicUnited States
-
University of California, DavisCompletedHematologic MalignanciesUnited States
-
PfizerCompletedAdvanced Non-Hematologic MalignanciesUnited Kingdom
-
AdaptimmuneTerminatedSolid and Hematological MalignanciesUnited States, Canada
-
Constellation PharmaceuticalsCompletedSolid Tumor | Advanced Malignancies | Hematological MalignancySpain, United States, Georgia
-
Gilead SciencesTerminatedHematological MalignanciesUnited States, United Kingdom
-
Senti BiosciencesRecruitingAML/MDS | CD33 Expressing Hematological Malignancies | FLT3 Expressing Hematological MalignanciesUnited States, Australia
-
PfizerTerminatedAdvanced Non-Hematologic MalignanciesUnited States, United Kingdom
-
University of Missouri-ColumbiaRecruiting
-
Henry Ford Health SystemRecruitingHematological MalignancyUnited States
-
AGC Biologics S.p.A.CompletedHematological MalignanciesItaly, Israel, United Kingdom, Germany, Greece
-
SanofiCompletedHematological MalignancyGreece, Spain, Peru, Israel, United States, Argentina, Belgium, Brazil, Chile, Finland, France, Italy, Mexico, Russian Federation, Turkey, Ukraine, United Kingdom
-
Washington University School of MedicineBarnes-Jewish HospitalTerminatedHematological MalignancyUnited States
-
M.D. Anderson Cancer CenterRecruiting
-
Royal Cornwall Hospitals TrustCompletedPalliative Care | Hematologic Malignancy | Oncology | End Stage CancerUnited Kingdom
-
Fate TherapeuticsTerminatedHematological MalignancyUnited States
-
Inova Health Care ServicesRecruitingSolid Tumor | Hematological MalignancyUnited States
-
Beckman Coulter, Inc.Completed
-
St. Jude Children's Research HospitalTerminated
-
Novartis PharmaceuticalsCompletedCancer Patients With Advanced Solid Tumors Including Lymphoma or Chronic Hematological MalignanciesUnited States
-
Medical University of South CarolinaTerminatedHematological MalignanciesUnited States
-
Mitchell Horwitz, MDCompletedHematological MalignanciesUnited States
-
Smart Immune SASRecruitingHematological MalignanciesUnited States
-
M.D. Anderson Cancer CenterCompletedHematological MalignanciesUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CompletedHematological MalignanciesUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)RecruitingHematologic MalignancyUnited States
-
AstraZenecaActive, not recruitingPediatric Cancer | Hematological Malignancies | Solid Tumor PediatricSpain, Italy, United States, United Kingdom, France, Netherlands, Germany
-
Spectrum Pharmaceuticals, IncOnxeoCompletedSolid Tumor | Hematological MalignancyUnited States
-
Century Therapeutics, Inc.RecruitingHematological Malignancy | Solid Tumor MalignancyUnited States
-
Gamida Cell ltdActive, not recruitingHematological MalignanciesUnited States
-
Astellas Pharma Global Development, Inc.Basilea Pharmaceutica International LtdCompletedHematological MalignancyUnited States
-
Rhizen Pharmaceuticals SACompletedHematological MalignanciesUnited States, Georgia, Poland
-
Esanex Inc.Completed
-
Rhode Island HospitalUnknownSolid Tumors | Hematological MalignanciesUnited States
-
Acrotech Biopharma Inc.Axis Clinicals LimitedCompletedSolid Tumor | Hematological MalignanciesUnited States
-
Kangpu Biopharmaceuticals, Ltd.RecruitingHematological MalignanciesUnited States
-
Imperial College LondonWithdrawnAllogeneic Stem Cell Transplant | Haematological Malignancies | CD56+CD3- NK CellsUnited Kingdom
-
NYU Langone HealthWithdrawnCancer | Hematological MalignancyUnited States
-
AstraZenecaRecruitingHematological MalignanciesUnited States, Spain, Korea, Republic of, Italy, Japan, Taiwan, Australia, Germany, China
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedHematopoietic/Lymphoid CancerUnited States
-
Acrotech Biopharma Inc.Axis Clinicals LimitedCompletedSolid Tumors | Hematological MalignanciesUnited States
-
AstraZenecaParexelActive, not recruitingAdvanced Haematological MalignanciesSpain, United States, Canada, Korea, Republic of, Poland, Australia, France, United Kingdom, Ireland
-
Acrotech Biopharma Inc.Axis Clinicals LimitedTerminatedRelapsed/Refractory Solid Tumors/Hematological MalignanciesUnited States
-
Merck Sharp & Dohme LLCActive, not recruitingHematological MalignanciesUnited States, Canada, Brazil, Chile, Denmark, France, Germany, Hungary, Israel, Italy, Poland, Russian Federation, Spain, Taiwan, Turkey, Ukraine
-
Nottingham University Hospitals NHS TrustNewcastle University; University of Kansas; Macmillan Cancer Support; Bishop Grosseteste...TerminatedCancer | Oncologic Disorders | Nutrition Aspect of Cancer | Haematological MalignancyUnited Kingdom
-
University College, LondonMedical Research CouncilCompletedHaematological MalignanciesUnited Kingdom